Filtered By:
Specialty: Drugs & Pharmacology
Condition: Heart Disease

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 187 results found since Jan 2013.

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
Conclusion: In T2DM patients, the SGLT2-I significantly reduced the inflammatory burden and ameliorated clinical outcomes at 5 years of follow-up post-CABG via MiECC.
Source: Frontiers in Pharmacology - November 15, 2021 Category: Drugs & Pharmacology Source Type: research

Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis
ConclusionsCombination therapy reduced the incidence of MI in ACS patients, but the risk of bleeding from intracranial hemorrhaging outweighs the benefit of MACE driven by MI. That is due to combination therapy having no positive impact on mortality; thus, the benefit –risk balance may be more favorable  in patients with stable CAD.
Source: Drugs - November 3, 2021 Category: Drugs & Pharmacology Source Type: research

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis
Conclusion Patients inheritingCYP2C19 loss-of-function alleles have significantly increased risk of major adverse cardiovascular events when taking clopidogrel and proton pump inhibitors concurrently.
Source: International Journal of Clinical Pharmacy - October 1, 2021 Category: Drugs & Pharmacology Source Type: research

Comparative Risk of Arterial Thromboembolic Events Between Aflibercept and Ranibizumab in Patients with Maculopathy: A Population-Based Retrospective Cohort Study
ConclusionThe use of aflibercept in patients with maculopathy was associated with a lower risk of ATE than was the use of ranibizumab. There was no difference in mortality risk between the two groups. Our study could provide strong grounds for future prospective studies to confirm the findings.
Source: BioDrugs - September 8, 2021 Category: Drugs & Pharmacology Source Type: research

Research Progress on Catalpol as Treatment for Atherosclerosis
Coronary atherosclerotic heart disease, cerebrovascular disease, and peripheral artery disease are common diseases with high morbidity and mortality rates and must be addressed. Their most frequent complications, including myocardial infarction and stroke, are caused by spontaneous thrombotic occlusion and are the most frequent cause of death worldwide. Atherosclerosis (AS) is the most widespread underlying pathological change for the above diseases. Therefore, drugs that interfere with this pathophysiological process must be incorporated in the treatment. Chinese traditional and herbal drugs can effectively treat AS. With...
Source: Frontiers in Pharmacology - July 13, 2021 Category: Drugs & Pharmacology Source Type: research

Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases
Curr Pharm Des. 2021 Jul 1. doi: 10.2174/1381612827666210701154305. Online ahead of print.ABSTRACTA large percentage of people are being exposed to mortality due to cardiovascular diseases. Convention approaches have not provided satisfactory outcomes in the management of these diseases. To overcome the limitations of conventional approaches, nanomaterials like nanoparticles, nanotubes, micelles, lipid based nanocarriers, dendrimers, carbon based nano-formulations represent the new aspect of diagnosis and treatment of cardiovascular diseases. The unique inherent properties of the nanomaterials are the major reasons for the...
Source: Current Pharmaceutical Design - July 5, 2021 Category: Drugs & Pharmacology Authors: Rakesh K Sahoo Himani Singh Kamlesh Thakur Umesh Gupta Amit K Goyal Source Type: research

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis
Conclusion Patients inheritingCYP2C19 loss-of-function alleles have significantly increased risk of major adverse cardiovascular events when taking clopidogrel and proton pump inhibitors concurrently.
Source: International Journal of Clinical Pharmacy - March 28, 2021 Category: Drugs & Pharmacology Source Type: research

Bempedoic acid: a cholesterol lowering agent with a novel mechanism of action
Expert Rev Clin Pharmacol. 2021 Mar 11. doi: 10.1080/17512433.2021.1901579. Online ahead of print.ABSTRACTINTRODUCTION: Dyslipidemia is a common condition that increases the risk of heart diseases and stroke. High levels of low-density lipoprotein-cholesterol (LDL-C) is correlated with a higher risk for heart disease. A drug class known as "statins" is the gold standard for LDL-C-lowering, but its use in some patients is limited by its adverse effects of myalgias and myopathies. Use of other LDL-C-lowering agents are frequently limited by cost and degree of efficacy. Additionally, many high-risk atherosclerotic cardiovascu...
Source: Expert Review of Clinical Pharmacology - March 11, 2021 Category: Drugs & Pharmacology Authors: Huyen Nguyen Ikenna Akamnonu Tianrui Yang Source Type: research

U.S. trends in prescription nonsteroidal anti ‐inflammatory drug use among patients with cardiovascular disease, 1988–2016
ConclusionsPrescription NSAID use among patients with CVD appears to have declined from 1988 to 2016, primarily due to reduced COX ‐2‐selective inhibitor use. Nonetheless, the prevalence of prescription NSAIDs has persisted among a subset of high‐risk CVD populations.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - March 9, 2021 Category: Drugs & Pharmacology Authors: Andrew Y. Hwang, Steven M. Smith Tags: ORIGINAL RESEARCH ARTICLE Source Type: research

Modeling of diagnosis for metabolic syndrome by integrating symptoms into physiochemical indexes
CONCLUSION: Compared with SVM and DT models, the RF model showed the best performance, especially when the ratio of the training set to test set is 8:2. Compared with single predictive indexes, the model constructed by combining physiochemical indexes with TCM indexes (i.e. the fused indexes) exhibited better predictive ability. In addition to common physicochemical indexes, some TCM indexes, such as wiry pulse, chest tightness, spontaneous perspiration, greasy tongue coating, can also improve diagnosis of MS.PMID:33588265 | DOI:10.1016/j.biopha.2021.111367
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 15, 2021 Category: Drugs & Pharmacology Authors: Shu-Jie Xia Bi-Zhen Gao Shui-Hua Wang David S Guttery Can-Dong Li Yu-Dong Zhang Source Type: research

Modeling of diagnosis for metabolic syndrome by integrating symptoms into physiochemical indexes.
CONCLUSION: Compared with SVM and DT models, the RF model showed the best performance, especially when the ratio of the training set to test set is 8:2. Compared with single predictive indexes, the model constructed by combining physiochemical indexes with TCM indexes (i.e. the fused indexes) exhibited better predictive ability. In addition to common physicochemical indexes, some TCM indexes, such as wiry pulse, chest tightness, spontaneous perspiration, greasy tongue coating, can also improve diagnosis of MS. PMID: 33588265 [PubMed - as supplied by publisher]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 12, 2021 Category: Drugs & Pharmacology Authors: Xia SJ, Gao BZ, Wang SH, Guttery DS, Li CD, Zhang YD Tags: Biomed Pharmacother Source Type: research

Impact of Sex on Office White Coat Effect Tail: A Review.
Abstract Office white-coat effect tail (OWCET) is defined as a decrease of ≥10 mmHg in systolic blood pressure (SBP) between successive measurements after its waxing during an office visit. The influence of sex on the incidence of long-term major fatal and non-fatal cardiovascular events was studied in two Italian populational cohorts [from the Gubbio Study and the Italian Rural Areas of the Seven Countries Study (IRA)]. OWCET increased risk of cardiovascular disease (CVD) [HR: 1.591 (95%CI: 1.204-2.103)], coronary heart disease (CHD) [HR: 1.614 (95%CI: 1.037-2.512)] and stroke (STR) [HR: 1.696 (95%CI: 1.123-2.5...
Source: Current Pharmaceutical Design - January 12, 2021 Category: Drugs & Pharmacology Authors: Humbert X, Fedrizzi S, Hofferer A, Bansard M, Huet AL, Bedier C, Rabiaza A, Le Bas J, Bas FL, Alexandre J, Puddu PE Tags: Curr Pharm Des Source Type: research